




Searching News Database: cell therapy
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 30 Jan 2025
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
HSMN NewsFeed - 3 Dec 2024
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
HSMN NewsFeed - 26 Nov 2024
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
HSMN NewsFeed - 22 Nov 2024
U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE(TM) Cord Blood Cell Therapy Product
U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE(TM) Cord Blood Cell Therapy Product
HSMN NewsFeed - 26 Jun 2024
BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn(R) Clinical Trial
BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn(R) Clinical Trial
HSMN NewsFeed - 20 Jun 2024
BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer
BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer
HSMN NewsFeed - 28 May 2024
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView(TM) Monitoring System
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView(TM) Monitoring System
HSMN NewsFeed - 2 May 2024
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
HSMN NewsFeed - 11 Apr 2024
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
HSMN NewsFeed - 14 Feb 2024
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
HSMN NewsFeed - 1 Nov 2023
cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer
cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer
HSMN NewsFeed - 3 Aug 2023
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
HSMN NewsFeed - 28 Feb 2023
Verismo Therapeutics Announces $7 Million Pre-Series A with BRV Capital Management as Lead Investor
Verismo Therapeutics Announces $7 Million Pre-Series A with BRV Capital Management as Lead Investor
HSMN NewsFeed - 3 Feb 2023
Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer
Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer
HSMN NewsFeed - 25 Oct 2022
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
HSMN NewsFeed - 29 Jun 2022
Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer
Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer
HSMN NewsFeed - 28 Mar 2022
Avenge Bio Appoints Claudio Dansky Ullmann, M.D., as Chief Medical Officer
Avenge Bio Appoints Claudio Dansky Ullmann, M.D., as Chief Medical Officer
HSMN NewsFeed - 22 Feb 2022
MicroVention Announces First U.S. Patient Treated with FRED(TM) X(TM) Flow Diverter Featuring X Technology
MicroVention Announces First U.S. Patient Treated with FRED(TM) X(TM) Flow Diverter Featuring X Technology
HSMN NewsFeed - 10 Feb 2022
GentiBio Appoints Industry Veteran Chuck Silberstein as Chief Financial Officer
GentiBio Appoints Industry Veteran Chuck Silberstein as Chief Financial Officer
HSMN NewsFeed - 26 Jan 2022
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
HSMN NewsFeed - 17 Jan 2022
CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation
CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation
HSMN NewsFeed - 7 Oct 2021
AffyImmune Therapeutics Announces $30M Series A+ Financing from ORI Capital
AffyImmune Therapeutics Announces $30M Series A+ Financing from ORI Capital
HSMN NewsFeed - 13 Sep 2021
ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer
ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer
HSMN NewsFeed - 27 Jul 2021
Umoja Biopharma Expands Management Team with Key Hires in Research and Business Development
Umoja Biopharma Expands Management Team with Key Hires in Research and Business Development
HSMN NewsFeed - 14 Jul 2021
Terumo Introduces New AZUR(TM) Vascular Plug and PG Pro(TM) Peripheral Microcatheter Embolization System
Terumo Introduces New AZUR(TM) Vascular Plug and PG Pro(TM) Peripheral Microcatheter Embolization System
HSMN NewsFeed - 8 Jun 2021
Umoja Biopharma Announces Appointment of David Fontana, Ph.D., as Chief Business and Strategy Officer
Umoja Biopharma Announces Appointment of David Fontana, Ph.D., as Chief Business and Strategy Officer
HSMN NewsFeed - 17 May 2021
AffyImmune Therapeutics' AIC100 Granted Fast Track Designation for Treating Thyroid Cancer
AffyImmune Therapeutics' AIC100 Granted Fast Track Designation for Treating Thyroid Cancer
HSMN NewsFeed - 11 May 2021
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
HSMN NewsFeed - 10 Feb 2021
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
HSMN NewsFeed - 18 Jan 2021
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
HSMN NewsFeed - 12 Jan 2021
Lower-Profile Web Intrasaccular Aneurysm Treatment Device Receives FDA Approval
Lower-Profile Web Intrasaccular Aneurysm Treatment Device Receives FDA Approval
HSMN NewsFeed - 6 Jan 2021
Myeloid Therapeutics Launches with Over $50 Million in Financing and Two Clinical Trials
Myeloid Therapeutics Launches with Over $50 Million in Financing and Two Clinical Trials
HSMN NewsFeed - 1 Dec 2020
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
HSMN NewsFeed - 17 Nov 2020
Celularity Announces Appointments of Chief Medical Officer and Senior Vice President of Regulatory Affairs
Celularity Announces Appointments of Chief Medical Officer and Senior Vice President of Regulatory Affairs
HSMN NewsFeed - 15 Jul 2020
Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field
Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field
HSMN NewsFeed - 8 Jul 2020
APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
HSMN NewsFeed - 7 May 2020
Caribou Biosciences and MaxCyte Enter into Clinical and Commercial License Agreement
Caribou Biosciences and MaxCyte Enter into Clinical and Commercial License Agreement
HSMN NewsFeed - 22 Apr 2020
Novartis Kymriah(R) receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma
Novartis Kymriah(R) receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma
HSMN NewsFeed - 28 Oct 2019
Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board
Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board
HSMN NewsFeed - 14 Oct 2019
Magnetic Insight Announces the Appointment of David Panzarella as Chief Commercial Officer
Magnetic Insight Announces the Appointment of David Panzarella as Chief Commercial Officer
HSMN NewsFeed - 1 Oct 2019
Astellas Commits Nearly $13 Million to Fund Boston-Area Start-Up Innovation in Cell and Gene Therapy
Astellas Commits Nearly $13 Million to Fund Boston-Area Start-Up Innovation in Cell and Gene Therapy
HSMN NewsFeed - 12 Sep 2019
I-Mab Biopharma Expands Global Team, Appoints Neil K. Warma As General Manager of I-Mab U.S.
I-Mab Biopharma Expands Global Team, Appoints Neil K. Warma As General Manager of I-Mab U.S.
HSMN NewsFeed - 12 Aug 2019
CASI Pharmaceuticals Announces Launch of EVOMELA(R) (melphalan for injection) in China
CASI Pharmaceuticals Announces Launch of EVOMELA(R) (melphalan for injection) in China
HSMN NewsFeed - 8 Aug 2019
Bayer Acquires Bluerock Therapeutics to Build Leading Position in Cell Therapy
Bayer Acquires Bluerock Therapeutics to Build Leading Position in Cell Therapy
HSMN NewsFeed - 17 Jun 2019
CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy
CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy
HSMN NewsFeed - 31 May 2019
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
HSMN NewsFeed - 29 Mar 2019
Allogeneic CAR-T Specialists TC BioPharm Appoint Prof John Anderson as Scientific and Medical Director
Allogeneic CAR-T Specialists TC BioPharm Appoint Prof John Anderson as Scientific and Medical Director
HSMN NewsFeed - 25 Feb 2019
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies
HSMN NewsFeed - 7 Feb 2019
Marker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development
Marker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development
HSMN NewsFeed - 3 Jan 2019
Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company
Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company
HSMN NewsFeed - 29 Nov 2018
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
HSMN NewsFeed - 26 Nov 2018
BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
HSMN NewsFeed - 14 Nov 2018
Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement
Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement
HSMN NewsFeed - 20 Sep 2018
BlueRock Therapeutics Appoints Shane Kovacs as Chief Business and Financial Officer
BlueRock Therapeutics Appoints Shane Kovacs as Chief Business and Financial Officer
HSMN NewsFeed - 30 Aug 2018
RootPath Raises $7 Million Seed Round led by Sequoia China to Accelerate Its Cancer Immunotherapy Programs
RootPath Raises $7 Million Seed Round led by Sequoia China to Accelerate Its Cancer Immunotherapy Programs
HSMN NewsFeed - 1 Jun 2018
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
HSMN NewsFeed - 30 Apr 2018
Adicet Bio appoints Elizabeth "EJ" Read, M.D. as Chief Technology Officer
Adicet Bio appoints Elizabeth "EJ" Read, M.D. as Chief Technology Officer
HSMN NewsFeed - 21 Mar 2018
TCR2 Therapeutics Raises $125 Million in Oversubscribed Series B Financing
TCR2 Therapeutics Raises $125 Million in Oversubscribed Series B Financing
HSMN NewsFeed - 29 Nov 2017
Capricor Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for CAP-1002
Capricor Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for CAP-1002
HSMN NewsFeed - 28 Aug 2017
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
HSMN NewsFeed - 17 Aug 2017
BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub, Appoints Key R&D Leadership
BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub, Appoints Key R&D Leadership
HSMN NewsFeed - 18 Jul 2017
U.S. FDA Designates Mallinckrodt's StrataGraft(R) as Regenerative Medicine Advanced Therapy
U.S. FDA Designates Mallinckrodt's StrataGraft(R) as Regenerative Medicine Advanced Therapy
HSMN NewsFeed - 12 Jul 2017
Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
HSMN NewsFeed - 18 Apr 2017
RXi Pharmaceuticals Announces New Chief Development Officer and Key Management Changes
RXi Pharmaceuticals Announces New Chief Development Officer and Key Management Changes
HSMN NewsFeed - 10 Apr 2017
Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
HSMN NewsFeed - 4 Apr 2017
NantKwest and Viracta Therapeutics Announce Series B Financing and Immunotherapy Partnership
NantKwest and Viracta Therapeutics Announce Series B Financing and Immunotherapy Partnership
HSMN NewsFeed - 8 Mar 2017
Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in the USA
Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in the USA
HSMN NewsFeed - 9 Jan 2017
Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies
Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies
HSMN NewsFeed - 12 Oct 2016
RXi Pharmaceuticals Enters into Exclusive Option Agreement to Acquire MirImmune Inc.
RXi Pharmaceuticals Enters into Exclusive Option Agreement to Acquire MirImmune Inc.
HSMN NewsFeed - 28 Jul 2016
Caladrius Biosciences Receives FDA Fast Track Designation for CLBS03 to Treat Recent Onset Type 1 Diabetes
Caladrius Biosciences Receives FDA Fast Track Designation for CLBS03 to Treat Recent Onset Type 1 Diabetes
HSMN NewsFeed - 20 May 2016
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
HSMN NewsFeed - 29 Oct 2015
Bellicum Appoints Alan K. Smith as Senior Vice President of Manufacturing
Bellicum Appoints Alan K. Smith as Senior Vice President of Manufacturing
HSMN NewsFeed - 12 Aug 2015
Japan Grants Safety Clearance to Pluristem's PLX-PAD Cells for Use in Clinical Trials
Japan Grants Safety Clearance to Pluristem's PLX-PAD Cells for Use in Clinical Trials
HSMN NewsFeed - 30 Jul 2015
Japanese Approval Trial for Stress Urinary Incontinence Using Cytori Cell Therapy Announced
Japanese Approval Trial for Stress Urinary Incontinence Using Cytori Cell Therapy Announced
HSMN NewsFeed - 15 Jul 2015
Histogenics Corporation Announces Dr. Gloria Matthews as Chief Medical Officer
Histogenics Corporation Announces Dr. Gloria Matthews as Chief Medical Officer
HSMN NewsFeed - 15 Jul 2015
Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research
Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research
HSMN NewsFeed - 12 Jun 2015
Cesca Therapeutics Board of Directors Appoint Robin C. Stracey as Chief Executive Officer
Cesca Therapeutics Board of Directors Appoint Robin C. Stracey as Chief Executive Officer
HSMN NewsFeed - 17 Feb 2015
BioRestorative Therapies Announces the Appointment of Edward Field as President of the brtxDISC(TM) Division
BioRestorative Therapies Announces the Appointment of Edward Field as President of the brtxDISC(TM) Division
HSMN NewsFeed - 27 Aug 2014
Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing
Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing
HSMN NewsFeed - 16 Jun 2014
Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business
Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business
HSMN NewsFeed - 14 Apr 2014
Kite Pharma Expands Leadership Team and Announces Senior Management Promotions
Kite Pharma Expands Leadership Team and Announces Senior Management Promotions
HSMN NewsFeed - 11 Apr 2014
Kite Pharma Expands Company's Board of Directors with the Appointment of Jonathan M. Peacock
Kite Pharma Expands Company's Board of Directors with the Appointment of Jonathan M. Peacock
HSMN NewsFeed - 26 Mar 2014
Cesca Therapeutics Submits pre-IDE Information Package to FDA for Surgwerks(TM) CLI therapy System
Cesca Therapeutics Submits pre-IDE Information Package to FDA for Surgwerks(TM) CLI therapy System
HSMN NewsFeed - 5 Feb 2014
Pluristem Strengthens Executive Team; Announces Senior Executive Appointments
Pluristem Strengthens Executive Team; Announces Senior Executive Appointments
HSMN NewsFeed - 29 Jan 2014
Bioheart Announces First Adipose Derived Stem Cell Implantation in Azerbaijan
Bioheart Announces First Adipose Derived Stem Cell Implantation in Azerbaijan
HSMN NewsFeed - 21 Jan 2014
Pluristem's Phase I/II Muscle Injury Trial Successfully Meets Primary Safety & Efficacy Endpoints
Pluristem's Phase I/II Muscle Injury Trial Successfully Meets Primary Safety & Efficacy Endpoints
HSMN NewsFeed - 6 Jan 2014
Fibrocell Science Appoints Robert Sheroff, Vice President of Technical Operations
Fibrocell Science Appoints Robert Sheroff, Vice President of Technical Operations
HSMN NewsFeed - 20 Dec 2013
Synta Announces Appointment of Steven Bernitz as Senior Vice President, Corporate Development
Synta Announces Appointment of Steven Bernitz as Senior Vice President, Corporate Development
HSMN NewsFeed - 19 Dec 2013
ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors
ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors
HSMN NewsFeed - 12 Dec 2013
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
HSMN NewsFeed - 25 Oct 2013
Bioheart Announces Agreement With Anosis to Distribute Products in the Middle East
Bioheart Announces Agreement With Anosis to Distribute Products in the Middle East
HSMN NewsFeed - 22 Jul 2013
SynGen Hires Former Pall Medical Executive as President of Cord Blood Business Unit
SynGen Hires Former Pall Medical Executive as President of Cord Blood Business Unit
HSMN NewsFeed - 27 Mar 2013
Bioheart's Appeals to the FDA for Compassionate Use Designation to Save Lives
Bioheart's Appeals to the FDA for Compassionate Use Designation to Save Lives
HSMN NewsFeed - 12 Mar 2013
TiGenix to Obtain National Reimbursement in Spain for Its Innovative Cartilage Therapy ChondroCelect(R)
TiGenix to Obtain National Reimbursement in Spain for Its Innovative Cartilage Therapy ChondroCelect(R)
HSMN NewsFeed - 28 Nov 2012
Smith & Nephew Announces Agreement To Acquire Assets Of Healthpoint Biotherapeutics
Smith & Nephew Announces Agreement To Acquire Assets Of Healthpoint Biotherapeutics
HSMN NewsFeed - 15 Nov 2012
Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
HSMN NewsFeed - 1 Nov 2012
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
HSMN NewsFeed - 15 Oct 2012
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
HSMN NewsFeed - 11 May 2012
InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell Research
InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell Research
HSMN NewsFeed - 28 Feb 2012
Baxter Initiates Phase III Adult Stem Cell Clinical Trial for Chronic Cardiac Condition
Baxter Initiates Phase III Adult Stem Cell Clinical Trial for Chronic Cardiac Condition
HSMN NewsFeed - 28 Feb 2012
Bioheart Announces University of Miami as Clinical Site for ANGEL Trial of LipiCell(TM)
Bioheart Announces University of Miami as Clinical Site for ANGEL Trial of LipiCell(TM)
HSMN NewsFeed - 14 Feb 2012
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
HSMN NewsFeed - 14 Nov 2011
Athersys Announces Recovery of All Rights to Cardiovascular Cell Therapy Program
Athersys Announces Recovery of All Rights to Cardiovascular Cell Therapy Program
HSMN NewsFeed - 12 Oct 2011
Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
HSMN NewsFeed - 6 Sep 2011
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
HSMN NewsFeed - 9 Jun 2011
Northwest Biotherapeutics Announces Change and Expansion of Management Team
Northwest Biotherapeutics Announces Change and Expansion of Management Team
HSMN NewsFeed - 6 May 2011
Cytori Announces Clyde W. Shores as Executive Vice President of Marketing & Sales
Cytori Announces Clyde W. Shores as Executive Vice President of Marketing & Sales
HSMN NewsFeed - 7 Mar 2011
NeoStem Announces the Addition of Jason Kolbert as Vice President of Strategic Business Development
NeoStem Announces the Addition of Jason Kolbert as Vice President of Strategic Business Development
HSMN NewsFeed - 24 Jan 2011
BrainStorm Appoints Dr. Adrian Harel as Chief Operating Officer and Acting Chief Executive Officer
BrainStorm Appoints Dr. Adrian Harel as Chief Operating Officer and Acting Chief Executive Officer
HSMN NewsFeed - 24 Jan 2011
SpineSmith and Celling Technologies Announces New Vice President of Sales
SpineSmith and Celling Technologies Announces New Vice President of Sales
HSMN NewsFeed - 17 Dec 2010
Cardiac Stem-Cell Pioneer Capricor Raises nearly $2 Million from Broadview Ventures, Private Investors
Cardiac Stem-Cell Pioneer Capricor Raises nearly $2 Million from Broadview Ventures, Private Investors
HSMN NewsFeed - 21 Sep 2010
Athersys Receives Orphan Drug Designation for MultiStem in Graft vs. Host Disease
Athersys Receives Orphan Drug Designation for MultiStem in Graft vs. Host Disease
HSMN NewsFeed - 10 Aug 2010
FDA Approves Innovative Liver Cell Therapy for Clinical Trial in the U.S.
FDA Approves Innovative Liver Cell Therapy for Clinical Trial in the U.S.
HSMN NewsFeed - 1 Jul 2010
SpineSmith Partners and Celling Technologies Hire New VP of Research and Development
SpineSmith Partners and Celling Technologies Hire New VP of Research and Development
HSMN NewsFeed - 29 Jun 2010
Cardio3 BioSciences Reports Positive Three-Month Data From its Clinical Trial of C-Cure(R) in Heart Failure
Cardio3 BioSciences Reports Positive Three-Month Data From its Clinical Trial of C-Cure(R) in Heart Failure
HSMN NewsFeed - 16 Jun 2010
SanBio Receives FDA Clearance to Initiate Cell Therapy Clinical Studies for Stroke Recovery
SanBio Receives FDA Clearance to Initiate Cell Therapy Clinical Studies for Stroke Recovery
HSMN NewsFeed - 6 May 2010
ThermoGenesis Names Leading Healthcare Industry Executive David Carter to Board of Directors
ThermoGenesis Names Leading Healthcare Industry Executive David Carter to Board of Directors
HSMN NewsFeed - 7 Apr 2010
Entest BioMedical, Inc. Announces the Addition of New Chief Financial Officer to Management Team
Entest BioMedical, Inc. Announces the Addition of New Chief Financial Officer to Management Team
HSMN NewsFeed - 6 Apr 2010
Fibrocell Science, Inc. Announces Addition of Marc B. Mazur to Board of Directors
Fibrocell Science, Inc. Announces Addition of Marc B. Mazur to Board of Directors
HSMN NewsFeed - 3 Mar 2010
CaridianBCT Receives 510(k) Clearance on Latest Version of Trima Accel Automated Blood Collection System
CaridianBCT Receives 510(k) Clearance on Latest Version of Trima Accel Automated Blood Collection System
HSMN NewsFeed - 2 Dec 2009
Seasoned Clinical Development Expert Joins Opexa to Lead Tovaxin(R) Development in Multiple Sclerosis
Seasoned Clinical Development Expert Joins Opexa to Lead Tovaxin(R) Development in Multiple Sclerosis
HSMN NewsFeed - 23 Sep 2009
Cook Medical's Advanced NavAlign Delivery System for IVC Filters Adds Procedural Speed, Control and Accuracy
Cook Medical's Advanced NavAlign Delivery System for IVC Filters Adds Procedural Speed, Control and Accuracy
HSMN NewsFeed - 23 Sep 2009
Cook Incorporated Wins Patent Infringement Appeal Filed By Edwards Lifesciences
Cook Incorporated Wins Patent Infringement Appeal Filed By Edwards Lifesciences
HSMN NewsFeed - 10 Sep 2009
Stem Cell Therapy International Inc. Announces Histostem Litigation Settlement
Stem Cell Therapy International Inc. Announces Histostem Litigation Settlement
HSMN NewsFeed - 11 Aug 2009
Breakthrough Drug-Eluting Stent to Treat Peripheral Arterial Disease Now Available in Europe
Breakthrough Drug-Eluting Stent to Treat Peripheral Arterial Disease Now Available in Europe
HSMN NewsFeed - 30 Jul 2009
Cardiogenesis Corporation Makes Pre-IDE Submission for PHOENIX Combination Delivery System
Cardiogenesis Corporation Makes Pre-IDE Submission for PHOENIX Combination Delivery System
HSMN NewsFeed - 15 Jul 2009
Cook Medical Announces FDA Clearance for Advance(R) 35LP PTA Balloon Dilatation Catheter
Cook Medical Announces FDA Clearance for Advance(R) 35LP PTA Balloon Dilatation Catheter
HSMN NewsFeed - 14 Jul 2009
Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial
Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial
HSMN NewsFeed - 16 Jun 2009
Pluristem Therapeutics Receives European Regulatory Approval for Placental-Derived Stem Cell Clinical Trial
Pluristem Therapeutics Receives European Regulatory Approval for Placental-Derived Stem Cell Clinical Trial
HSMN NewsFeed - 26 May 2009
First High-Definition Endoscopic Ultrasound (EUS) Technology Enhances Diagnostic Procedures
First High-Definition Endoscopic Ultrasound (EUS) Technology Enhances Diagnostic Procedures
HSMN NewsFeed - 7 May 2009
New Study Shows that Zilver PTX from Cook Medical Effectively Treats Blockages in Critical Thigh Artery
New Study Shows that Zilver PTX from Cook Medical Effectively Treats Blockages in Critical Thigh Artery
HSMN NewsFeed - 27 Apr 2009
Study Finds Cook Medical Resonance Metallic Ureteral Stent Provides 43 Percent Cost Savings
Study Finds Cook Medical Resonance Metallic Ureteral Stent Provides 43 Percent Cost Savings
HSMN NewsFeed - 19 Mar 2009
Cook Incorporated Resolves To Pursue Further German Infringement Action Against Edwards Lifesciences
Cook Incorporated Resolves To Pursue Further German Infringement Action Against Edwards Lifesciences
HSMN NewsFeed - 6 Feb 2009
Advanced Wound Technologies Mid-Atlantic, Inc. Announces Name Change and Reverse Stock Split
Advanced Wound Technologies Mid-Atlantic, Inc. Announces Name Change and Reverse Stock Split
HSMN NewsFeed - 2 Feb 2009
SCOLR Pharma, Inc. Announces Appointment of Bruce S. Morra, Ph.D., as President & CEO
SCOLR Pharma, Inc. Announces Appointment of Bruce S. Morra, Ph.D., as President & CEO
HSMN NewsFeed - 19 Jan 2009
Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding
Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding
HSMN NewsFeed - 15 Jan 2009
Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product
Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product
HSMN NewsFeed - 16 Dec 2008
Bioheart, Inc. Announces Plans to Divest Non-Core Products to Increase Focus On Heart Failure Treatments
Bioheart, Inc. Announces Plans to Divest Non-Core Products to Increase Focus On Heart Failure Treatments
HSMN NewsFeed - 30 Oct 2008
Cook Medical Introduces Ciaglia Blue Dolphin(TM) Percutaneous Dilational Tracheostomy Device
Cook Medical Introduces Ciaglia Blue Dolphin(TM) Percutaneous Dilational Tracheostomy Device
HSMN NewsFeed - 27 Oct 2008
Cook Medical Receives CE Mark Approval for MiraFlex(TM) High Flow Microcatheter
Cook Medical Receives CE Mark Approval for MiraFlex(TM) High Flow Microcatheter
HSMN NewsFeed - 20 Oct 2008
Cook Medical Announces the North American Launch of Advance(R) 18LP PTA Balloon Dilatation Catheter
Cook Medical Announces the North American Launch of Advance(R) 18LP PTA Balloon Dilatation Catheter
HSMN NewsFeed - 30 Sep 2008
Cook Medical Continues to Drive Endoscopy Innovations with Industry's Strongest 3 Stage Balloon Dilator
Cook Medical Continues to Drive Endoscopy Innovations with Industry's Strongest 3 Stage Balloon Dilator
HSMN NewsFeed - 23 Sep 2008
Greg MacMichael, Ph.D., Joins Cook Pharmica as Vice President of Development, CSO
Greg MacMichael, Ph.D., Joins Cook Pharmica as Vice President of Development, CSO
HSMN NewsFeed - 9 Sep 2008
ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
HSMN NewsFeed - 5 Sep 2008
Invitrogen Names Joe Beery Senior Vice President, Chief Information Officer
Invitrogen Names Joe Beery Senior Vice President, Chief Information Officer
HSMN NewsFeed - 1 Aug 2008
Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
HSMN NewsFeed - 11 Jul 2008
Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
HSMN NewsFeed - 7 Jul 2008
Foothills Medical Centre Adopts Newest Technology for the Removal of Pacemaker Leads
Foothills Medical Centre Adopts Newest Technology for the Removal of Pacemaker Leads
HSMN NewsFeed - 3 Jul 2008
Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
HSMN NewsFeed - 9 Jun 2008
Cook Medical Announces FDA 510(k) Clearance of Evolution(R) Controlled Release Esophageal Stent System
Cook Medical Announces FDA 510(k) Clearance of Evolution(R) Controlled Release Esophageal Stent System
HSMN NewsFeed - 3 Jun 2008
Invitrogen Receives FDA Clearance for Diagnostic System to Determine Transplant Compatibility
Invitrogen Receives FDA Clearance for Diagnostic System to Determine Transplant Compatibility
HSMN NewsFeed - 3 Jun 2008
Cook Medical Announces First-In-Man Use of Next Generation Aortic Aneurysm Endograft and Delivery System
Cook Medical Announces First-In-Man Use of Next Generation Aortic Aneurysm Endograft and Delivery System
HSMN NewsFeed - 23 May 2008
Cook Medical Receives FDA Approval for Advanced Thoracic Aortic Aneurysm Endovascular Graft
Cook Medical Receives FDA Approval for Advanced Thoracic Aortic Aneurysm Endovascular Graft
HSMN NewsFeed - 12 May 2008
Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device
Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device
HSMN NewsFeed - 31 Mar 2008
Cook Medical Advances Staple Line Reinforcement with Self-Adhesive Surgisis Biodesign
Cook Medical Advances Staple Line Reinforcement with Self-Adhesive Surgisis Biodesign
HSMN NewsFeed - 20 Mar 2008
Cook Incorporated Wins Judgment In Patent Infringement Suit Filed By Edwards
Cook Incorporated Wins Judgment In Patent Infringement Suit Filed By Edwards
HSMN NewsFeed - 19 Mar 2008
Cook Medical Announces the Launch and First Patient Enrollment of the REFORM Clinical Trial
Cook Medical Announces the Launch and First Patient Enrollment of the REFORM Clinical Trial
HSMN NewsFeed - 17 Mar 2008
Bioheart Founder, Howard J. Leonhardt, Becomes Chairman of the Board of Directors
Bioheart Founder, Howard J. Leonhardt, Becomes Chairman of the Board of Directors
HSMN NewsFeed - 17 Mar 2008
Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs
Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs
HSMN NewsFeed - 14 Mar 2008
Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
HSMN NewsFeed - 12 Mar 2008
Advanced Cell Technology and Catholic Healthcare West Sign Clinical Agreement
Advanced Cell Technology and Catholic Healthcare West Sign Clinical Agreement
HSMN NewsFeed - 21 Feb 2008
ImmunoCellular Therapeutics Announces New President and Chief Executive Officer
ImmunoCellular Therapeutics Announces New President and Chief Executive Officer
HSMN NewsFeed - 11 Feb 2008
Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers
Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers
HSMN NewsFeed - 11 Feb 2008
Cook Medical Introduces Umbilical Hernia Graft Designed to Fit Individual Patient Anatomies
Cook Medical Introduces Umbilical Hernia Graft Designed to Fit Individual Patient Anatomies
HSMN NewsFeed - 11 Feb 2008
Cook Medical Enrolls First U.S. Patient in STABLE Aortic Dissection Trial
Cook Medical Enrolls First U.S. Patient in STABLE Aortic Dissection Trial
HSMN NewsFeed - 6 Feb 2008
Cook Pharmica Announces $80 Million Expansion to its Bloomington Biopharmaceutical Facility
Cook Pharmica Announces $80 Million Expansion to its Bloomington Biopharmaceutical Facility
HSMN NewsFeed - 4 Feb 2008
Cook Medical Names Christina Anne Vice President for Its Women's Health Business Unit
Cook Medical Names Christina Anne Vice President for Its Women's Health Business Unit
HSMN NewsFeed - 30 Jan 2008
First Patients Treated in Cytori's Stem & Regenerative Cell Heart Attack Study
First Patients Treated in Cytori's Stem & Regenerative Cell Heart Attack Study
HSMN NewsFeed - 24 Jan 2008
Cook Incorporated Files IDE Application for Zenith Branch Vessel Graft with U.S. FDA
Cook Incorporated Files IDE Application for Zenith Branch Vessel Graft with U.S. FDA
HSMN NewsFeed - 9 Jan 2008
Ortec Shareholders Approve Corporate Name Change to Forticell Bioscience, Inc.
Ortec Shareholders Approve Corporate Name Change to Forticell Bioscience, Inc.
HSMN NewsFeed - 8 Jan 2008
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
HSMN NewsFeed - 7 Jan 2008
Cardica Receives $2 Million Payment From Cook Medical for Successful Completion of Multiple Milestones
Cardica Receives $2 Million Payment From Cook Medical for Successful Completion of Multiple Milestones
HSMN NewsFeed - 11 Dec 2007
Organogenesis, Inc. Signs Memorandum of Understanding with Chinese Regenerative Medicine Company
Organogenesis, Inc. Signs Memorandum of Understanding with Chinese Regenerative Medicine Company
HSMN NewsFeed - 7 Nov 2007
Advanced Cell Technology Announces 12-Month Results of Myoblast Therapy Trial
Advanced Cell Technology Announces 12-Month Results of Myoblast Therapy Trial
HSMN NewsFeed - 22 Oct 2007
New Stem Cell Treatment Reduces Amputations in Critical Limb Ischemia (CLI)
New Stem Cell Treatment Reduces Amputations in Critical Limb Ischemia (CLI)
HSMN NewsFeed - 18 Oct 2007
Aastrom Stem Cell Therapy Demonstrates Positive Results in Severe Long Bone Non-Union Fracture Trial
Aastrom Stem Cell Therapy Demonstrates Positive Results in Severe Long Bone Non-Union Fracture Trial
HSMN NewsFeed - 20 Sep 2007
Cook Medical and Cardica Sign Agreement to Expand Cook Vascular Closure Device Product Family
Cook Medical and Cardica Sign Agreement to Expand Cook Vascular Closure Device Product Family
HSMN NewsFeed - 13 Sep 2007
Aldagen Raises Additional $9 Million, Increasing Series C Financing to $23 Million
Aldagen Raises Additional $9 Million, Increasing Series C Financing to $23 Million
HSMN NewsFeed - 11 Sep 2007
Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis
Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis
HSMN NewsFeed - 7 Sep 2007
Arbios Systems Publishes Positive Results From Completed Sepet(TM) Feasibility Clinical Trial
Arbios Systems Publishes Positive Results From Completed Sepet(TM) Feasibility Clinical Trial
HSMN NewsFeed - 6 Aug 2007
Cook Medical Announces Breakthrough Device for Diagnosis of Abnormal Uterine Bleeding
Cook Medical Announces Breakthrough Device for Diagnosis of Abnormal Uterine Bleeding
HSMN NewsFeed - 1 Aug 2007
Advanced Cell Technology Enters Into Definitive Merger Agreement With Mytogen, Inc.
Advanced Cell Technology Enters Into Definitive Merger Agreement With Mytogen, Inc.
Additional items found! 163

Members Archive contains
163 additional stories matching:
cell therapy
(Password required)
cell therapy
(Password required)